[HTML][HTML] Bullous pemphigoid

D Miyamoto, CG Santi, V Aoki… - Anais brasileiros de …, 2019 - SciELO Brasil
Bullous pemphigoid is the most frequent autoimmune bullous disease and mainly affects
elderly individuals. Increase in incidence rates in the past decades has been attributed to …

Pemphigoid diseases

E Schmidt, D Zillikens - The Lancet, 2013 - thelancet.com
Pemphigoid diseases are a group of well defined autoimmune disorders that are
characterised by autoantibodies against structural proteins of the dermal–epidermal junction …

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

L Borradori, N Van Beek, C Feliciani… - Journal of the …, 2022 - Wiley Online Library
Background Bullous pemphigoid (BP) is the most common autoimmune subepidermal
blistering disease of the skin and mucous membranes. This disease typically affects the …

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

C Feliciani, P Joly, MF Jonkman… - British journal of …, 2015 - academic.oup.com
Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of
the skin and mucous membranes. This disease typically affects the elderly and presents with …

Bullous pemphigoid: a review of its diagnosis, associations and treatment

P Bernard, F Antonicelli - American journal of clinical dermatology, 2017 - Springer
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease
in Western countries, and typically affects the elderly. BP is immunologically characterized …

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts

DF Murrell, BS Daniel, P Joly, L Borradori… - Journal of the American …, 2012 - Elsevier
Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent
years. However, despite the availability of various therapeutic options for the treatment of …

[HTML][HTML] Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

HC Williams, F Wojnarowska, G Kirtschig, J Mason… - The Lancet, 2017 - thelancet.com
Background Bullous pemphigoid is a blistering skin disorder with increased mortality. We
tested whether a strategy of starting treatment with doxycycline gives acceptable short-term …

Bullous pemphigoid

IS Bağcı, ON Horváth, T Ruzicka, M Sárdy - Autoimmunity reviews, 2017 - Elsevier
Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is
characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous …

[图书][B] Comprehensive dermatologic drug therapy

SE Wolverton, JJ Wu - 2019 - books.google.com
Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th
Edition, helps you safely and effectively treat the skin disorders you're likely to see in your …

Diagnosis and classification of autoimmune blistering diseases

S Baum, N Sakka, O Artsi, H Trau, A Barzilai - Autoimmunity reviews, 2014 - Elsevier
Blistering skin diseases are a group of autoimmune disorders that are characterized by
autoantibodies against structural proteins of the epidermis or the dermal–epidermal junction …